ANALYSIS: Investors have lost millions and companies have collapsed, but medicinal cannabis players still see a bright future.
What are fund managers doing in this volatile time? Battle lines have been drawn.
The spate of recent takeover bids for listed companies will be giving NZX the jitters.
Have you heard of search funds?
Has Xero thrown in the towel in the US?
Shoeshine: Thwarted by underinvestment, can it come back from the brink?
Shoeshine: Glass Lewis thinks Infratil has a diversity problem.
Rocks thrown over passive and active approaches.
Analysis: Will the cutbacks bear fruit?